Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Enzyme Inhib Med Chem. 2015 Feb;30(1):81-4. doi: 10.3109/14756366.2014.880696. Epub 2014 Mar 25.

Investigation of arenesulfonyl-2-imidazolidinones as potent carbonic anhydrase inhibitors.

Author information

  • 1Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University , Riyadh , Saudi Arabia .

Abstract

A series of arenesulfonyl-2-imidazolidinones incorporating methyl, isopropyl, methoxy, halogen and phenyl moieties were prepared and tested as possible inhibitors of two members of the pH regulatory enzyme family, carbonic anhydrase (CA; EC 4.2.1.1). The inhibitory potencies of the compounds against human isoforms hCA I and hCA II were analyzed by an esterase assay with 4-nitrophenyl acetate as substrate, and the inhibition constants (KI) were calculated. Most compounds investigated here exhibited micromolar inhibition constants against the two isoenzymes. KI values were in the range of 10.2-40.6 μM for hCA I and of 13.1-31.4 μM for hCA II, respectively. Most of the imidazolidinones showed interesting CA inhibitory efficacy, some of them having comparable affinity (for hCA I) as the clinically used sulfonamide acetazolamide (AZA), but their efficacy against hCA II was much lower compared to AZA.

KEYWORDS:

Carbonic anhydrase; glaucoma; imidazolidinone; inhibitor

PMID:
24666299
[PubMed - in process]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Informa Healthcare
    Loading ...
    Write to the Help Desk